Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials

Clowse, Megan E. B., Wallace, Daniel J., Furie, Richard A., Petri, Michelle A., Pike, Marilyn C., Szűcs, Gabriella, EMBODY, Investigator Group, Kemény, Lajos, et, al.: Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.
ARTHRITIS & RHEUMATOLOGY, 69 (2). pp. 362-375. ISSN 2326-5191 (2017)

[img]
Preview
Text
3217512_Clowse.pdf - Published Version

Download (360kB) | Preview
Item Type: Article
Szerzők száma: 295
Journal or Publication Title: ARTHRITIS & RHEUMATOLOGY
Date: 2017
Volume: 69
Number: 2
Page Range: pp. 362-375
ISSN: 2326-5191
Publisher: John Wiley and Sons, Inc.
Faculty: Faculty of Medicine
Institution: Szegedi Tudományegyetem
MTMT id: 3217512
DOI id: https://doi.org/10.1002/art.39856
Date Deposited: 2018. Jan. 17. 10:06
Last Modified: 2020. Jan. 31. 16:27
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/12731
Web of Science® Times Cited: 76 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year